Demonstrating Better Protection with 3 Flu Shots in Myeloma | Craig Hofmeister, MD, MPH | #ASH24

Demonstrating Better Protection with 3 Flu Shots in Myeloma | Craig Hofmeister, MD, MPH | #ASH24
High-Fiber NUTRIVENTION Study for Delaying Progression of Myeloma | Urvi Shah, MD | #ASH24
Does enhanced genetic testing impact myeloma patients? | Santiago Thibaud, MD | #ASH24
Loss of CD38 and Resistance Patterns in Myeloma | Benjamin Diamond, MD | #ASH24
IVIG and Preventing Infections in Myeloma Patients on Teclistamab | Heloise Cheruvalath | #ASH24
CAR-T Efficacy for Myeloma Patients with Bispecific Exposure | Johannes Waldschmidt, MD | #ASH24
New Insights for Amyloidosis in Myeloma | Suzanne Lentzsch, MD | #ASH24
What are the precursor conditions of multiple myeloma?